Ron Cohen M.D.
Net Worth

Last updated:

What is Ron Cohen M.D. net worth?

The estimated net worth of Dr. Ron Cohen M.D. is at least $54,445,568 as of 17 Mar 2023. He has earned $25,945,568 from insider trading and has received compensation worth at least $28,500,000 in Acorda Therapeutics, Inc..

What is the salary of Ron Cohen M.D.?

Dr. Ron Cohen M.D. salary is $1,500,000 per year as Founder, Chief Executive Officer, Pres & Director in Acorda Therapeutics, Inc..

How old is Ron Cohen M.D.?

Dr. Ron Cohen M.D. is 69 years old, born in 1956.

What stocks does Ron Cohen M.D. currently own?

As insider, Dr. Ron Cohen M.D. owns shares in one company:

Company Title Shares Price per share Total value
Acorda Therapeutics, Inc. (ACOR) Founder, Chief Executive Officer, Pres & Director 149,757 $0 $0

What does Acorda Therapeutics, Inc. do?

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.

ACOR logo
ACOR
Acorda Therapeutics, Inc.

Ron Cohen M.D. insider trading

Acorda Therapeutics, Inc.

Dr. Ron Cohen M.D. has made 40 insider trades between 2006-2023, according to the Form 4 filled with the SEC. Most recently he purchased 10,000 units of ACOR stock worth $6,500 on 17 Mar 2023.

The largest trade he's ever made was exercising 172,723 units of ACOR stock on 20 Aug 2013. As of 17 Mar 2023 he still owns at least 149,757 units of ACOR stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 $0.65 $6,500
Purchase
Common Stock 10,156 $0.6 $6,094
Sale
Common Stock 2,289 $1.7 $3,894
Sale
Common Stock 4,699 $1.6 $7,504
Sale
Common Stock 3,620 $20.6 $74,554
Option
Common Stock 62,500 N/A N/A
Option
Employee Stock Option (right to buy) 62,500 N/A N/A
Purchase
Common Stock 20,000 $16.95 $339,000
Option
Employee Stock Option (right to buy) 40,172 N/A N/A
Option
Common Stock 40,172 N/A N/A
Sale
Common Stock 40,172 $21.05 $845,540
Sale
Common Stock 7,160 $20.74 $148,484
Option
Common Stock 29,238 $7.16 $209,432
Option
Employee Stock Option (right to buy) 25,233 $7.75 $195,430
Option
Common Stock 29,238 $9.11 $266,446
Sale
Common Stock 11,850 $38.08 $451,224
Option
Common Stock 910 $30.1 $27,391
Sale
Common Stock 910 $30.1 $27,391
Option
Employee Stock Option (right to buy) 910 $30.1 $27,391
Sale
Common Stock 134,090 $28.01 $3,756,129
Option
Employee Stock Option (right to buy) 134,090 $7.46 $1,000,311
Option
Common Stock 134,090 $7.46 $1,000,311
Option
Employee Stock Option (right to buy) 51,265 N/A N/A
Option
Common Stock 51,265 N/A N/A
Sale
Common Stock 34,394 $35.59 $1,224,151
Sale
Common Stock 18,125 $33.52 $607,478
Option
Employee Stock Option (right to buy) 51,406 $2.6 $133,656
Sale
Common Stock 31,945 $34.54 $1,103,221
Option
Common Stock 172,723 $2.6 $449,080
Option
Common Stock 55,993 $34.02 $1,904,882
Option
Employee Stock Option (right to buy) 55,993 $34.02 $1,904,882
Sale
Common Stock 55,993 $34.02 $1,904,882
Option
Common Stock 61,062 $1.3 $79,381
Sale
Common Stock 61,062 $34.04 $2,078,550
Option
Employee Stock Option (right to buy) 61,062 $1.3 $79,381
Sale
Common Stock 11,000 $34.15 $375,650
Sale
Common Stock 16,407 $24.22 $397,410
Sale
Common Stock 16,500 $22.92 $378,180
Sale
Common Stock 12,000 $30.87 $370,440
Sale
Common Stock 60,000 N/A N/A
Option
Employee Stock Option (right to buy) 60,000 N/A N/A
Option
Common Stock 60,000 N/A N/A
Sale
Common Stock 60,000 N/A N/A
Option
Common Stock 60,000 N/A N/A
Option
Employee Stock Option (right to buy) 60,000 N/A N/A
Sale
Common Stock 15,000 $26.65 $399,675
Option
Employee Stock Option (right to buy) 17,094 $2.6 $44,444
Option
Common Stock 18,696 $2.6 $48,610
Sale
Common Stock 55,000 $36.18 $1,989,900
Option
Employee Stock Option (right to buy) 55,000 $2.6 $143,000
Option
Common Stock 55,000 $2.6 $143,000
Option
Common Stock 19,000 $2.6 $49,400
Sale
Common Stock 19,000 $2.6 $49,400
Option
Employee Stock Option (right to buy) 19,000 $2.6 $49,400
Sale
Common Stock 19,000 $2.6 $49,400
Option
Employee Stock Option (right to buy) 19,000 $2.6 $49,400
Option
Common Stock 19,000 $2.6 $49,400
Sale
Common Stock 8,500 $24.51 $208,293
Sale
Common Stock 4,000 $15.89 $63,560
Sale
Common Stock 25,000 $29.65 $741,325
Option
Employee Stock Option (right to buy) 25,000 $2.6 $65,000
Option
Common Stock 25,000 $2.6 $65,000
Option
Employee Stock Option (right to buy) 25,000 $2.6 $65,000
Option
Common Stock 25,000 $2.6 $65,000
Sale
Common Stock 25,000 $31.26 $781,425
Option
Common Stock 50,000 $2.6 $130,000
Sale
Common Stock 50,000 $31.83 $1,591,600
Option
Employee Stock Option (right to buy) 50,000 $1.3 $65,000
Option
Employee Stock Option (right to buy) 31,432 $0.87 $27,252
Option
Common Stock 31,432 $2.6 $81,723
Sale
Common Stock 30,632 $19.7 $603,389
Sale
Restricted Stock 8,100 $17.66 $143,038
Sale
Restricted Stock 8,000 $20.32 $162,576
Sale
Restricted Stock 8,000 $16.02 $128,160
Sale
Restricted Stock 26,000 $16.92 $440,024
Sale
Restricted Stock 26,000 $16.75 $435,474
Sale
Restricted Stock 26,000 $16.78 $436,332
Sale
Restricted Stock 26,000 $17.71 $460,512
Sale
Common Stock 800 $19.55 $15,640
Sale
Common stock 7,591 $18.82 $142,863
Sale
Common Stock 100,000 $17.1 $1,710,000
Sale
Common Stock 100,000 $16.38 $1,638,300

Acorda Therapeutics key executives

Acorda Therapeutics, Inc. executives and other stock owners filed with the SEC: